Navigation Links
Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Six Years With Similar Safety Profile Observed in Original Fracture Trial
Date:11/5/2011

policies may affect the development, usage and pricing of our products. In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products. We believe that some of our newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Our products may compete against products that have lower prices, established reimbursement, superior performance, are easier to administer, or that are otherwise competitive with our products. In addition, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors and there can be no guarantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and ef
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
2. Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
3. Treatment With Prolia® (denosumab) Associated With Significantly Greater Adherence, Compliance and Persistence Compared to Alendronate
4. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
5. XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
6. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
7. Results Published in The Lancet Demonstrate Superiority of XGEVA™ (Denosumab) in the Prevention of Bone Complications for Men With Bone Metastases From Advanced Prostate Cancer
8. The Journal of Clinical Oncology Publishes Phase 3 XGEVA™ (Denosumab) Results in Advanced Cancer Patients With Solid Tumors or Multiple Myeloma
9. XGEVA™ (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
10. Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
11. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014 Jazz Pharmaceuticals plc (Nasdaq: ... corporate presentations at two upcoming investor conferences.  , ... on Tuesday, December 2, 2014 at 6:45 a.m. EST ... and head of EUSA International, will provide an overview of the ... Annual Piper Jaffray Healthcare Conference in New York, ...
(Date:11/26/2014)... Nov. 26, 2014 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based on ... unaudited financial results for the third quarter ended September 30, ... 2014: , Same store sales increased by 8.1% ... Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) compared ...
(Date:11/24/2014)... , Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. ... conducted in Melbourne, Australia ... the potential treatment of paroxysmal supraventricular tachycardia (PSVT).  ... MSP-2017 was well tolerated at single doses up ... safety profile, desirable PK properties including rapid onset, ...
Breaking Medicine Technology:Jazz Pharmaceuticals Announces Participation in Two Investor Conferences 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
(Date:11/26/2014)... (PRWEB) November 26, 2014 News ... showcase expanded capabilities at RSNA 2014 in Chicago. ... manage and share diagnostic images, photos, videos and ... Perceptive’s booth #8107 will learn more about these ... acquired technologies and partner initiatives – that enable ...
(Date:11/26/2014)... One of the most important and vital decisions a ... is choosing the ideal wedding dress and bridesmaid dresses. ... high quality outfits. Today, BellasDress.com has unveiled its new ... their suitable bridesmaid gowns here at discount prices. , ... scintillating and highlight all their most beautiful features while ...
(Date:11/26/2014)... News) -- Vultures have developed highly specialized ways of ... dead animals, researchers report. The new research investigated ... and in the guts of 50 turkey vultures and ... faces of the vultures had more than 500 different ... the study found. The findings suggest that a ...
(Date:11/26/2014)... of emergency department visits in the United States rose from ... in 2011, according to the U.S. Centers for Disease Control ... were going to ERs with non-urgent medical needs: 96 percent ... hours of arriving at the ER. In 2010, that number ... of patients arrived at the ER after normal business hours ...
(Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. ... the U.S. Food and Drug Administration will have many restaurant ... even apply to movie theater popcorn and ice cream parlor ... away from home, often consuming less nutritious food and underestimating ... during a Monday afternoon news conference. Although listing ...
Breaking Medicine News(10 mins):Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Royal Blue Bridesmaid Dresses Now Are Available for Christmas at BellasDress.com 2Health News:ER Visits on the Rise, Study Reports 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 2Health News:Calorie Counts Mandated at Chain Restaurants, FDA Says 3
... Oct. 29 /PRNewswire/ - Halogen Software Inc., the ... software,today announced that Vonage has selected Halogen eAppraisal ... services, is,moving to a Web-based system to streamline ... focus on delivering top-notch services to its,customers. ...
... American Football players has found that more than a third ... , In his study of homosexuality among sportsmen in the ... sample of 47 had taken part in acts intended to ... and oral sex. , The 47 men, aged 18-23, were ...
... When cells become cancerous, the sugars on their ... healthy cells. For decades, scientists have tried to exploit ... cancerous cells before they can spread and ravage the ... Cancer Center have synthesized a carbohydrate-based vaccine that ...
... LOS ANGELES, Oct. 28 Disparities in access ... socioeconomically disadvantaged populations from receiving needed cancer services ... determine the lasting impact of cancer education geared ... Medical Center (UPMC), in partnership with The Centers ...
... Research on Cancer (IARC) have now added breast cancer ... where alcohol is a contributing cause. Even moderate consumption ... day increases a womans breast cancer risk by 7%-10%. ... Toronto Cancer Prevention Coalition and the Centre for Addiction ...
... Growth Plans, DALLAS, Oct. 29 Crdentia ... company, today announced it has,completed a private placement ... this offering will be used for working capital ... focusing on internal,organic growth throughout the Sun Belt ...
Cached Medicine News:Health News:Vonage Selects Halogen Software - New Solution to Streamline Employee Performance and Talent Management Across Organization 2Health News:Over one-third of former American football players had sexual relations with men, study says 2Health News:Over one-third of former American football players had sexual relations with men, study says 3Health News:UGA researchers 1 step closer to elusive cancer vaccine 2Health News:UGA researchers 1 step closer to elusive cancer vaccine 3Health News:Education program leads to lasting improvement of cancer knowledge in African-Americans 2Health News:Alcohol and cancer -- recent research and prevention opportunities 2Health News:Crdentia Announces Completion of $5M Financing 2Health News:Crdentia Announces Completion of $5M Financing 3
... primers and a FAM-labeled probe that is designed ... probe to detect Flu B. In addition, this ... for a separate sample processing control. This ASR ... 532 and Texas Red reporter dyes such as ...
...
Digital Ultrasonic Diagnostic Imaging System...
...
Medicine Products: